Zhijian J. Xiao
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020
Tianjin, 301600, China
Tianjin, 301600, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 292 publications
Germline DDX41 mutations and myelodysplastic neoplasms
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
Comparative study of the prognostic value of survival prognostic scoring systems in patients with essential thrombocythemia: IPSET, MIPSS-ET, AAA, and AAA
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
Clinical characteristics and prognosis of myelodysplastic neoplasms with GATA2 mutations
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: July 06, 2026
Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.
Journal: Hematological oncology
Published: April 27, 2026
Genomic landscape, clinical correlates and prognostic implications of U2AF1 mutation subtypes in myelodysplastic neoplasms.
Journal: Blood cancer journal
Published: April 23, 2026
How I diagnose and treat chronic myelomonocytic leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 16, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.
Journal: Hematological oncology
Published: February 25, 2026
Clinical heterogeneity in congenital factor XII deficiency: Coexisting risk factors in thrombotic and bleeding events.
Journal: British journal of haematology
Published: February 24, 2026
External validation and incremental value assessment of the RR6 prognostic model in Chinese myelofibrosis patients treated with ruxolitinib: focusing on overall survival
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: February 09, 2026
Last Updated: 09/26/2026